← All tickers

Is GERN Worth Buying in 2026?

Geron Corp

STOCK PHARMACEUTICAL PREPARATIONS Updated 2026-04-19

Here’s whether Geron Corp (GERN) is worth buying in 2026 — based on weekly-updated price trend, RSI momentum, and return vs. the S&P 500. Our current read: Bullish.

🟢
Bullish

Positives: trading above the 200-day MA (long-term uptrend intact); above the 50-day MA (medium-term momentum positive); 50-day MA is rising (+3.89% over 10 days); strong 1-year return of +35.5%; 3-month momentum positive (+28.2%). Currently 16.4% off its 52-week high. Score: +6/7.

Ready to act on this? 📈 Trade on Webull

GERN is in a confirmed uptrend, trading above both its 50-day ($1.63) and 200-day ($1.39) moving averages. An RSI of 69.4 sits in the neutral zone — momentum is neither stretched nor exhausted. The 1-year return of +35.5% compares to +35.1% for SPY (beat the market by 0.4%).

$10,000 invested 1 year ago → $13,548 today
vs. S&P 500 (SPY) — same period beat market by 0.4%

1-Year Price Chart

Daily candles
MA-50 MA-200 Up Down

Signal Check

✓Above 200-day MA ($1.39)
✓Above 50-day MA ($1.63)
✓RSI(14) neutral zone (30–70) — currently 69.4
✓Positive return (+35.5%)
!Within 10% of period high (−16.4%)
Period Range $1.68
$1.04 $2.01
RSI (14) 69.4
0 · OversoldOverbought · 100

Key Metrics

Price$1.68
Period Return+35.5%
Period High$2.01
Period Low$1.04
Drawdown−16.4%
MA-50$1.63
MA-200$1.39
RSI (14)69.4
Avg Volume (30d)20.1M
vs. SPYbeat by 0.4%
Return Rank#459 of 996

Trade GERN

📈 Trade on Webull 📊 Trade on moomoo 💹 Interactive Brokers